Financials
- Market Capitalization 1.83 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.63 USD | -1.23% | -6.17% | -4.41% | +98.24% | 1.83 B USD | ||
| 2039 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.31 USD | -1.49% | -1.28% | +7.43% | +8.45% | 1.87 B USD | ||
| 2055 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.34 USD | +1.19% | +1.40% | +7.00% | +26.18% | 1.82 B USD | ||
| 2056 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | 0.00% | -4.03% | +9.90% | -29.15% | 1.78 B USD |